Cybersonics’ history goes back to 1970 when Dr. Roger Goodfriend, Chief of Surgery at Los Gatos Community Hospital, contacted Blackstone Ultrasonics to develop a vibrating lithotripter to pulverize kidney stones. In July 1972, Roger made medical history by becoming the first person in the world to successfully disintegrate kidney stones without cutting the patient.
In 1989, our president, Geoff Bond, lead a management buyout, believing strongly that the “Good Vibrations” would revolutionize various medical problems. Active programs within Blackstone Ultrasonics included activating a long flexible waveguide to ablate plaque in the peripheral vasculature.
By 1996, Blackstone Ultrasonics was a leading manufacturer in precision industrial cleaning with a growing medical division and the decision was made to split these two successful companies. The medical division, named Cybersonics, continued to grow and subsequently split again when it divested a line of surgical operating room lights, (NUVO, Inc.) in order to focus exclusively on its core technology for medical devices that utilize low frequency ultrasonic soundwaves.
New proprietary technology was developed that used a floating free mass and probe to convert and amplify ultrasonic energy into low frequency impact forces. Cybersonics received a massive morale boost when NASA selected and funded this technology to develop a rock drill for the Mars Rover Project; the CyberWand Lithotripter was derived from that program, and is now the gold standard for large stone lithotripsy.
Cybersonics currently owns 50 patents for a variety of medical applications and is developing several new products targeted at a variety of applications and markets.